HEADER OXIDOREDUCTASE 29-MAY-09 3HMZ TITLE CRYSTAL STRUCTURE OF A FMN-BINDING DOMAIN OF FLAVIN REDUCTASES-LIKE TITLE 2 ENZYME (SBAL_0626) FROM SHEWANELLA BALTICA OS155 AT 1.50 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: FLAVIN REDUCTASE DOMAIN PROTEIN, FMN-BINDING; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SHEWANELLA BALTICA; SOURCE 3 ORGANISM_TAXID: 325240; SOURCE 4 STRAIN: OS155; SOURCE 5 ATCC: BAA-1091; SOURCE 6 GENE: SBAL_0626, YP_001049024.1; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS FMN-BINDING DOMAIN OF FLAVIN REDUCTASES-LIKE ENZYME, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3HMZ 1 REMARK SEQADV REVDAT 5 24-JUL-19 3HMZ 1 REMARK LINK REVDAT 4 01-NOV-17 3HMZ 1 REMARK REVDAT 3 13-JUL-11 3HMZ 1 VERSN REVDAT 2 28-JUL-10 3HMZ 1 TITLE KEYWDS REVDAT 1 30-JUN-09 3HMZ 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF FMN-BINDING DOMAIN OF FLAVIN JRNL TITL 2 REDUCTASES-LIKE ENZYME (YP_001049024.1) FROM SHEWANELLA JRNL TITL 3 BALTICA OS155 AT 1.50 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0053 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.29 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 38596 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.130 REMARK 3 R VALUE (WORKING SET) : 0.129 REMARK 3 FREE R VALUE : 0.150 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1933 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.54 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2674 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.1970 REMARK 3 BIN FREE R VALUE SET COUNT : 143 REMARK 3 BIN FREE R VALUE : 0.2280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1470 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 219 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.45000 REMARK 3 B22 (A**2) : 0.45000 REMARK 3 B33 (A**2) : -0.67000 REMARK 3 B12 (A**2) : 0.22000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.060 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.052 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.031 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.886 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.979 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.974 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1680 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1105 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2305 ; 1.758 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2720 ; 1.395 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 224 ; 4.932 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 80 ;34.181 ;25.125 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 269 ;11.900 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 7 ;14.589 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 254 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1904 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 333 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1005 ; 1.943 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 403 ; 1.031 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1631 ; 2.726 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 675 ; 2.347 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 656 ; 3.322 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 2785 ; 1.469 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 229 ; 8.267 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 2735 ; 3.804 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 3. ETHYLNE GLYCOL (EDO) AND IMIDAZOLE (IMD) REMARK 3 MOLECULES FROM THE CRYOPROTECTION/PURIFICATION SOLUTIONS ARE REMARK 3 MODELED. 4. COFACTOR MOLECULE FMN IS MODELED BASED ON THE REMARK 3 ELCTRON DENSITY. 5. AN UNKNOWN LIGAND (UNL) HAS BEEN MODELED REMARK 3 NEAR FMN. REMARK 4 REMARK 4 3HMZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-JUN-09. REMARK 100 THE DEPOSITION ID IS D_1000053332. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97797 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38635 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 26.288 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.1500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.85300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STATISTICS REPORTED IN REMARK 200 WERE COMPUTED REMARK 200 WITH XSCALE WITH FRIEDEL PAIRS KEPT SEPARATE. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.22 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M SODIUM THIOCYANATE, 20.0000% REMARK 280 PEG-3350, NO BUFFER PH 6.9, ADDITIVE: 0.0009M FLAVIN-ADENINE REMARK 280 DINUCLEOTIDE (FAD), VAPOR DIFFUSION, SITTING DROP, NANODROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.70233 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 49.40467 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 49.40467 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 24.70233 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS SUGGESTS THE ASSIGNMENT OF A REMARK 300 DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 111.94050 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 64.62888 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 24.70233 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 GLN A 4 REMARK 465 ARG A 5 REMARK 465 LYS A 6 REMARK 465 THR A 7 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 8 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN A 196 O HOH A 404 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FMN A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UNL A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMD A 199 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 205 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 375054 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3HMZ A 1 198 UNP A3D092 A3D092_SHEB5 1 198 SEQADV 3HMZ GLY A 0 UNP A3D092 EXPRESSION TAG SEQRES 1 A 199 GLY MSE HIS HIS GLN ARG LYS THR HIS VAL ASP ASN ASN SEQRES 2 A 199 ILE ALA ALA VAL GLU LEU ALA LYS ALA TYR ARG LEU LEU SEQRES 3 A 199 ASN HIS GLY PRO THR VAL LEU VAL SER ALA ARG SER GLN SEQRES 4 A 199 GLY ILE ASP ASN VAL MSE ALA ALA ALA TRP CYS CYS ALA SEQRES 5 A 199 LEU ASP PHE ALA PRO PRO LYS LEU THR VAL VAL LEU ASP SEQRES 6 A 199 LYS MSE THR LYS THR ARG GLU PHE ILE GLU GLN SER GLY SEQRES 7 A 199 MSE PHE VAL ILE GLN VAL PRO THR VAL ALA GLN LEU GLN SEQRES 8 A 199 LEU THR HIS ARG VAL GLY SER GLN SER LEU ALA ASP ASP SEQRES 9 A 199 ALA ASN LYS LEU LEU ASN CYS GLY VAL GLU LEU PHE GLU SEQRES 10 A 199 MSE ALA GLY HIS ASP LEU PRO PHE VAL ALA GLY CYS SER SEQRES 11 A 199 ALA TRP LEU ALA CYS LYS LEU ILE PRO GLU PRO ASN ASN SEQRES 12 A 199 GLN LEU GLN TYR ASP LEU PHE ILE ALA GLU VAL ILE GLY SEQRES 13 A 199 ALA TRP ALA ASP THR GLN VAL PHE ASN HIS GLY HIS TRP SEQRES 14 A 199 HIS PHE ASP THR ALA PRO ALA ASP LYS ARG SER LEU HIS SEQRES 15 A 199 TYR ILE ALA GLY GLY GLN PHE TYR ALA ILE GLY GLU SER SEQRES 16 A 199 PHE ASN ALA ASP MODRES 3HMZ MSE A 44 MET SELENOMETHIONINE MODRES 3HMZ MSE A 66 MET SELENOMETHIONINE MODRES 3HMZ MSE A 78 MET SELENOMETHIONINE MODRES 3HMZ MSE A 117 MET SELENOMETHIONINE HET MSE A 44 8 HET MSE A 66 18 HET MSE A 78 13 HET MSE A 117 8 HET FMN A 500 31 HET UNL A 501 5 HET IMD A 199 5 HET EDO A 200 4 HET EDO A 201 4 HET EDO A 202 4 HET EDO A 203 4 HET EDO A 204 4 HET EDO A 205 4 HETNAM MSE SELENOMETHIONINE HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM UNL UNKNOWN LIGAND HETNAM IMD IMIDAZOLE HETNAM EDO 1,2-ETHANEDIOL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 4(C5 H11 N O2 SE) FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 4 IMD C3 H5 N2 1+ FORMUL 5 EDO 6(C2 H6 O2) FORMUL 11 HOH *219(H2 O) HELIX 1 1 GLU A 17 LEU A 25 5 9 HELIX 2 2 THR A 67 GLY A 77 1 11 HELIX 3 3 THR A 85 ALA A 87 5 3 HELIX 4 4 GLN A 88 GLY A 96 1 9 HELIX 5 5 SER A 99 ASP A 103 5 5 HELIX 6 6 ASN A 105 GLY A 111 1 7 HELIX 7 7 GLU A 139 ASP A 147 1 9 HELIX 8 8 PRO A 174 ARG A 178 5 5 SHEET 1 A 6 ILE A 13 ALA A 15 0 SHEET 2 A 6 LEU A 148 ASP A 159 -1 O ALA A 158 N ALA A 14 SHEET 3 A 6 ALA A 130 ILE A 137 -1 N ILE A 137 O ILE A 150 SHEET 4 A 6 MSE A 78 VAL A 83 -1 N PHE A 79 O CYS A 134 SHEET 5 A 6 VAL A 31 SER A 37 -1 N LEU A 32 O GLN A 82 SHEET 6 A 6 ILE A 40 ALA A 46 -1 O ALA A 46 N VAL A 31 SHEET 1 B 4 ILE A 13 ALA A 15 0 SHEET 2 B 4 LEU A 148 ASP A 159 -1 O ALA A 158 N ALA A 14 SHEET 3 B 4 LYS A 58 VAL A 62 -1 N VAL A 61 O PHE A 149 SHEET 4 B 4 CYS A 49 ASP A 53 -1 N CYS A 50 O THR A 60 SHEET 1 C 2 LEU A 114 PHE A 115 0 SHEET 2 C 2 PHE A 124 VAL A 125 -1 O PHE A 124 N PHE A 115 SHEET 1 D 2 PHE A 163 ASN A 164 0 SHEET 2 D 2 HIS A 167 TRP A 168 -1 O HIS A 167 N ASN A 164 SHEET 1 E 2 LEU A 180 ALA A 184 0 SHEET 2 E 2 GLN A 187 ALA A 190 -1 O GLN A 187 N ALA A 184 LINK C VAL A 43 N MSE A 44 1555 1555 1.33 LINK C MSE A 44 N ALA A 45 1555 1555 1.33 LINK C LYS A 65 N MSE A 66 1555 1555 1.33 LINK C MSE A 66 N THR A 67 1555 1555 1.34 LINK C GLY A 77 N MSE A 78 1555 1555 1.34 LINK C MSE A 78 N PHE A 79 1555 1555 1.33 LINK C GLU A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N ALA A 118 1555 1555 1.35 CISPEP 1 ALA A 55 PRO A 56 0 -2.25 SITE 1 AC1 24 ASN A 42 MSE A 44 ALA A 45 ALA A 46 SITE 2 AC1 24 ALA A 47 TRP A 48 VAL A 62 LEU A 63 SITE 3 AC1 24 ASP A 64 THR A 67 LYS A 68 THR A 69 SITE 4 AC1 24 VAL A 95 GLY A 96 GLN A 98 SER A 99 SITE 5 AC1 24 LEU A 100 LYS A 106 TYR A 182 PHE A 188 SITE 6 AC1 24 EDO A 202 HOH A 295 HOH A 305 UNL A 501 SITE 1 AC2 7 ASN A 26 TRP A 48 PHE A 54 EDO A 204 SITE 2 AC2 7 HOH A 362 HOH A 419 FMN A 500 SITE 1 AC3 4 GLY A 28 CYS A 49 CYS A 50 HOH A 241 SITE 1 AC4 8 ILE A 13 PHE A 115 ALA A 126 GLY A 127 SITE 2 AC4 8 HOH A 264 HOH A 300 HOH A 319 HOH A 412 SITE 1 AC5 5 LEU A 91 ARG A 94 CYS A 110 HOH A 265 SITE 2 AC5 5 HOH A 304 SITE 1 AC6 5 MSE A 66 SER A 97 GLN A 98 HOH A 295 SITE 2 AC6 5 FMN A 500 SITE 1 AC7 6 ALA A 19 ALA A 55 ALA A 87 ASP A 176 SITE 2 AC7 6 LYS A 177 HOH A 248 SITE 1 AC8 4 ASP A 64 ASP A 147 HOH A 388 UNL A 501 SITE 1 AC9 5 MSE A 66 THR A 67 LYS A 68 GLU A 71 SITE 2 AC9 5 HOH A 344 CRYST1 74.627 74.627 74.107 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013400 0.007736 0.000000 0.00000 SCALE2 0.000000 0.015473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013494 0.00000